ISO 24190:2023
ISO 24190:2023 Biotechnology – Analytical methods – Risk-based approach for method selection and validation for rapid microbial detection in bioprocesses
CDN $347.00
Description
This document provides guidance, a framework and a risk-based approach for the selection and validation of methods for rapid microbial detection in cellular therapeutic product manufacturing.
This document provides a flexible risk-based framework for the detection of microbial contamination in cellular therapeutic products and cellular intermediates.
This document provides general requirements and risks associated with cellular therapeutic product manufacturing, with flexibility to address differences in specific manufacturing processes of each unique cellular therapeutic product.
This document primarily addresses sterility testing in cellular therapeutic product manufacturing. This document is applicable to other cell-derived therapeutic product manufacturing.
This document focuses on rapid microbial test methods (RMTMs) used for both in-process and final product testing.
Viral testing in cellular therapeutic product manufacturing is not included in this document.
Edition
1
Published Date
2023-05-31
Status
PUBLISHED
Pages
44
Language
English
Format
Secure PDF
Secure – PDF details
- Save your file locally or view it via a web viewer
- Viewing permissions are restricted exclusively to the purchaser
- Device limits - 3
- Printing – Enabled only to print (1) copy
See more about our Environmental Commitment
Abstract
This document provides guidance, a framework and a risk-based approach for the selection and validation of methods for rapid microbial detection in cellular therapeutic product manufacturing.
This document provides a flexible risk-based framework for the detection of microbial contamination in cellular therapeutic products and cellular intermediates.
This document provides general requirements and risks associated with cellular therapeutic product manufacturing, with flexibility to address differences in specific manufacturing processes of each unique cellular therapeutic product.
This document primarily addresses sterility testing in cellular therapeutic product manufacturing. This document is applicable to other cell-derived therapeutic product manufacturing.
This document focuses on rapid microbial test methods (RMTMs) used for both in-process and final product testing.
Viral testing in cellular therapeutic product manufacturing is not included in this document.
Previous Editions
Can’t find what you are looking for?
Please contact us at:
Related Documents
-
ISO 80004:2020 Nanotechnologies – Vocabulary – Part 8: Nanomanufacturing processes
CDN $85.00 Add to cart -
ISO 80004:2011 Nanotechnologies – Vocabulary – Part 5: Nano/bio interface
CDN $85.00 Add to cart -
ISO 20537:2025 Footwear – Identification of defects during visual inspection – Vocabulary
CDN $305.00 Add to cart -
ISO 3833:1977 Road vehicles – Types – Terms and definitions
CDN $129.00 Add to cart
